HIV i-Base news story
When i-Base reported several GLP-1 studies in people living with HIV from CROI 2024, a discussion was included about whether anecdotal reports of breaking the dopamine reward pathway associated with reduced craving for food might help reduce dependence on chemsex drugs which currently have no effective treatment to support and manage withdrawal.
A new paper in the BMJ from a large observational database study now adds substantial data to this potential benefit for use in substance use disorder.
The results showed a clear and consistent reduction in the use of cannabis, cocaine, nicotine, opioid and other substances, together with reduced hospital visits, mortality and suicide.
Read the full news story here.
Â